EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells

Gabor Tax iD, Kevin P Guay, Ludovica Pantalone iD, Martina Ceci iD, Tatiana Soldà, Charlie J Hitchman iD, Johan C Hill iD, Snežana Vasiljević, Andrea Lia iD, Carlos P Modenutti iD, Kees R Straatman iD, Angelo Santino iD and 5 more

Traffic · 2024-01 · 25 (1)

DOI: 10.1111/tra.12927 ↗

At a glance

Journal article in Traffic, published online on 2024-01-14. Written by Gabor Tax and 16 co-authors. Institution: Leicester Institute of Chemical and Structural Biology and Department of Molecular and Cell Biology, University of Leicester, Leicester, England, UK. Major MEDLINE topics: Rare Diseases, Protein Folding. Cited 12 times so far (Crossref); 77 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, Swiss National Science Foundation, Wellcome Trust.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Endoplasmic reticulum (ER) retention of misfolded glycoproteins is mediated by the ER‐localized eukaryotic glycoprotein secretion checkpoint, UDP‐glucose glycoprotein glucosyl‐transferase (UGGT). The enzyme recognizes a misfolded glycoprotein and flags it for ER retention by re‐glucosylating one of its N ‐linked glycans. In the background of a congenital mutation in a secreted glycoprotein gene, UGGT‐mediated ER retention can cause rare disease, even if the mutant glycoprotein retains activity (“responsive mutant”). Using confocal laser scanning microscopy, we investigated here the subcellular localization of the human Trop‐2‐Q118E, E227K and L186P mutants, which cause gelatinous drop‐like corneal dystrophy (GDLD). Compared with the wild‐type Trop‐2, which is correctly localized at the plasma membrane, these Trop‐2 mutants are retained in the ER. We studied fluorescent chimeras of the Trop‐2 Q118E, E227K and L186P mutants in mammalian cells harboring CRISPR/Cas9‐mediated inhibition of the UGGT1 and/or UGGT2 genes. The membrane localization of the Trop‐2 Q118E, E227K and L186P mutants was successfully rescued in UGGT1 −/− cells. UGGT1 also efficiently reglucosylated Trop‐2‐Q118E‐EYFP in cellula . The study supports the hypothesis that UGGT1 modulation would constitute a novel therapeutic strategy for the treatment of pathological conditions associated to misfolded membrane glycoproteins (whenever the mutation impairs but does not abrogate function), and it encourages the testing of modulators of ER glycoprotein folding quality control as broad‐spectrum rescue‐of‐secretion drugs in rare diseases caused by responsive secreted glycoprotein mutants.

Subjects

MeSH terms (MEDLINE)

Rare DiseasesProtein FoldingAnimalsHumansGlycoproteinsEndoplasmic ReticulumMutationMammalsGlucosyltransferasesUDP-Galactose Translocators

Author keywords

GDLDTACSTD2Trop-2UGGTUGGT1UGGT2glycoprotein secretionresponsive mutant

Substances

GlycoproteinsGlucosyltransferasesUGGT1 protein, humanUDP-Galactose Translocators

Authors and institutions

  • Leicester Institute of Chemical and Structural Biology and Department of Molecular and Cell Biology, University of Leicester, Leicester, England, UK.
  • Department of Biochemistry and Molecular Biology, and Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, USA.
  • Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Pescara, Italy.
  • Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Pescara, Italy.
  • Institute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
  • Institute of Glycobiology, Department of Biochemistry, University of Oxford, Oxford, UK.

ORCID profiles: Gabor Tax, Ludovica Pantalone, Martina Ceci, Charlie J Hitchman, Johan C Hill, Andrea Lia, Carlos P Modenutti, Kees R Straatman, Angelo Santino, Maurizio Molinari, Nicole Zitzmann, Daniel N Hebert, Pietro Roversi, Marco Trerotola

Funding

  • NIGMS NIH HHS
  • Swiss National Science Foundation
  • Wellcome Trust
  • NIH HHS
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • University of Leicester
  • Biotechnology and Biological Sciences Research Council
  • National Institutes of Health

Cite

APA

Tax, G., Guay, K. P., Pantalone, L., Ceci, M., Soldà, T., Hitchman, C. J., Hill, J. C., Vasiljević, S., Lia, A., Modenutti, C. P., Straatman, K. R., Santino, A., Molinari, M., Zitzmann, N., Hebert, D. N., Roversi, P., & Trerotola, M. (2024). Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells. Traffic, 25(1). https://doi.org/10.1111/tra.12927

Vancouver

Tax G, Guay KP, Pantalone L, Ceci M, Soldà T, Hitchman CJ, et al. Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells. Traffic. 2024;25(1). doi:10.1111/tra.12927

BibTeX
@article{Tax2024,
  author = {Tax, Gabor and Guay, Kevin P and Pantalone, Ludovica and Ceci, Martina and Soldà, Tatiana and Hitchman, Charlie J and Hill, Johan C and Vasiljević, Snežana and Lia, Andrea and Modenutti, Carlos P and Straatman, Kees R and Santino, Angelo and Molinari, Maurizio and Zitzmann, Nicole and Hebert, Daniel N and Roversi, Pietro and Trerotola, Marco},
  title = {Rescue of secretion of rare‐disease‐associated misfolded mutant glycoproteins in UGGT1 knock‐out mammalian cells},
  journal = {Traffic},
  year = {2024},
  volume = {25},
  number = {1},
  doi = {10.1111/tra.12927}
}
Start for free →